alexa Determining the duration of therapy for patients with community-acquired pneumonia.


Journal of Antimicrobial Agents

Author(s): Scalera NM, File TM Jr

Abstract Share this page

Abstract Emerging data, including results from two systematic reviews, suggest that with appropriate antimicrobial selection, community-acquired pneumonia (CAP) can be successfully treated in less than 7 days, rather than the 7-14 days frequently utilized. Shorter course therapy has the potential not only to improve efficacy, safety, and compliance, but also to minimize the evolution of resistance. Utilization of procalcitonin as a biomarker in CAP can appropriately influence the duration of therapy without affecting mortality and cure rates. CAP treatment duration can further be reduced successfully into the clinical setting with the assistance of an antibiotic stewardship team. This article was published in Curr Infect Dis Rep and referenced in Journal of Antimicrobial Agents

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version